Table 2 Chemotherapy Regimens Used
Regimen | Number of patient treatments (N = 56) | Protocol |
|---|---|---|
Carboplatin | 1 | 5(GFR+25)mg;6 cycles; q3 wk |
Mitoxantrone | 1 | 12 mg/m2; q3 wk |
Treosulfan | 1 | 7000 mg/m2; q4 wk |
Gemcitabine | 1 | 1250 mg/m2; d1,8; q3 wk |
Treosulfan and gemcitabine | 23 | 5000 mg/m2; d1 & 1000 mg/m2; d1; q3 wk |
Liposomal Doxorubicin (Caelyx®/Doxil®) | 8 | 40 mg/m2; d1; q3 wk |
Mitoxantrone and paclitaxel | 8 | 4 mg/m2; d1,2 & 175 mg/m2; d3; q3 wk |
Cisplatin and gemcitabine | 5 | 75 mg/m2; d1 & 1250 mg/m2; d1,8; q3 wk |
Mitoxantrone and gemcitabine | 1 | 12 mg/m2; d1,21 & 1000 mg/m2; d1; q3 wk |
Liposomal Doxorubicin and gemcitabine | 1 | 45 mg/m2; d1 & 500 mg/m2; d1,8; q3 wk |
Epirubicin and treosulfan | 2 | 60 mg/m2; d1 & 5000 mg/m2; d1; q4 wk |
Vinorelbine and Liposomal Doxorubicin | 2 | 15 mg/m2 & 30 mg/m2 ; q3 wk |
Epirubicin and paclitaxel | 2 | 25 mg/m2; d1,2 & 175 mg/m2; d3; q3 wk |